## Review

### Soundness: **52/100**
The paper presents a plausible model and reports improvements over several baselines, but important methodological details are missing or potentially problematic:

- The construction of prediction windows and the exact onset-labeling procedure are not sufficiently specified. In particular, Sepsis-3 labels based on cultures, antibiotics, and organ dysfunction can introduce timestamp leakage if events occurring near or after the prediction time are included.
- The paper does not explain how measurements are aggregated within hourly windows, how multiple measurements are handled, or how missing values and demographic variables are represented.
- Baseline comparisons may be unfair. TimeWarn is tuned by grid search, whereas baselines use hyperparameters from their original papers, despite dataset and preprocessing differences.
- Statistical testing is absent. The reported improvements are relatively small, and confidence intervals or paired significance tests would help establish whether they are robust.
- The claimed interpretability of attention weights is not adequately validated. High attention to clinically relevant variables does not demonstrate that the weights are faithful explanations.
- The experimental description is insufficient for reproducibility: preprocessing, cohort exclusion criteria, onset definition, optimization details, and the exact five baselines’ implementations are not fully given.
- The reported results could be plausible, but without stronger safeguards against label and temporal leakage, the conclusions are not yet fully reliable.

### Novelty: **57/100**
The central idea—adding learned time-decay factors to RETAIN-style visit- and variable-level attention—is sensible, but the conceptual novelty appears limited. Related models such as GRU-D and other time-aware attention or continuous-time architectures already incorporate elapsed-time information. The paper would need a clearer distinction from existing time-aware attention methods and a more systematic comparison to establish that the proposed formulation is novel rather than a straightforward combination of known components.

### Significance: **67/100**
Early sepsis prediction is clinically important, and evaluating on MIMIC-IV and eICU is potentially valuable. Improvements over GRU-D and RETAIN, if valid and reproducible, could be meaningful. However, the practical significance is limited by the retrospective design, lack of calibration and decision-curve analysis, absence of external or prospective validation, and no assessment of alert burden or clinical utility. The paper demonstrates predictive discrimination but does not yet establish that TimeWarn would improve patient outcomes or workflow.

### Clarity: **73/100**
The manuscript is generally well organized and easy to follow. The motivation, architecture, experimental comparisons, and headline results are clearly presented. However, several details needed to understand and reproduce the work are unclear, including:

- exact cohort and exclusion criteria;
- temporal splitting and handling of repeat admissions;
- label and onset construction;
- hourly-window aggregation;
- imputation and normalization;
- the dimensionality and treatment of variable-level attention;
- whether attention weights are normalized after time decay;
- baseline implementation and tuning procedures;
- uncertainty estimation and statistical testing.

The paper also makes somewhat strong interpretability claims based on a simple average of attention weights.

## Scores

| Criterion | Score |
|---|---:|
| Soundness | 52 |
| Novelty | 57 |
| Significance | 67 |
| Clarity | 73 |
| **Final average** | **62.25/100** |

## Final recommendation: **Reject**

The problem is important and the proposed approach is reasonable, but the current manuscript does not provide enough methodological detail or validation to support its claims. A substantially revised version should address temporal and label leakage, use fair baseline tuning, provide complete preprocessing and cohort definitions, report statistical uncertainty, validate calibration and clinical utility, and clarify the contribution relative to existing time-aware models.